What is 'early onset dementia'?
- PMID: 19604328
- DOI: 10.1111/j.1479-8301.2009.00274.x
What is 'early onset dementia'?
Abstract
There are two types of dementia with early onset: (i) presenile dementias; and (ii) senile dementias with early onset. Most patients who develop dementia before 65 years of age have Alzheimer's disease (AD). The remainder are likely to have vascular dementia (VaD), frontotemporal dementia, head injury, alcohol intoxication, or metabolic disorder. Presenile dementias, caused by frontotemporal lobar degeneration, progressive supranuclear palsy, and corticobasal degeneration, usually occur in patients of presenile and are rarely seen in patients of senile age. Although the factors responsible for the accelerated onset of the illness are not fully known, genetic abnormalities appear to be important in some types of presenile dementia, such as frontotemporal dementia with parkinsonism linked to chromosome 17. Conversely, senile dementias such as sporadic AD and VaD commonly occur in patients of senile age. These disorders may also occur in patients of presenile age, although less frequently. Alzheimer's disease was originally classified as a 'presenile dementia'. Since the 1980s, 'senile dementia of Alzheimer type' (SDAT) and 'Alzheimer's disease' have been considered to belong to the same pathological entity and both are now known as 'dementia of Alzheimer's type (DAT)' or merely 'Alzheimer's disease'. Rapid progression of cognitive impairment with neuropsychological syndromes and neurological symptoms has been considered a characteristic of early onset AD. However, recently, neurological symptoms such as spastic paraparesis, seizures, and myoclonic convulsions have been reported to occur infrequently in early onset AD, although language problems and visuospatial dysfunctions are common. There are at least three dominant genes that have been identified in cases of familial Alzheimer's disease with early onset, namely the amyloid precursor gene (APP), and the genes encoding presenilin 1 (PSEN1) and presenilin 2 (PSEN2). Therefore, genetic abnormalities are important factors contributing to the earlier onset of the illness. It is also important to investigate the pathophysiological mechanism in relation to genetic abnormalities, environmental factors, physical illnesses, and metabolic disturbances to understand the processes underlying the development of dementia with early onset.
Similar articles
-
The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.Brain. 2011 Sep;134(Pt 9):2478-92. doi: 10.1093/brain/awr189. Epub 2011 Aug 11. Brain. 2011. PMID: 21840888
-
Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.Brain. 2004 Jul;127(Pt 7):1641-9. doi: 10.1093/brain/awh179. Epub 2004 May 6. Brain. 2004. PMID: 15130954
-
Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.Med Hypotheses. 2005;65(1):123-37. doi: 10.1016/j.mehy.2004.08.031. Med Hypotheses. 2005. PMID: 15893129
-
[Genetic predisposition to Alzheimer's disease].Rev Neurol. 1997 Aug;25(144):1285-8. Rev Neurol. 1997. PMID: 9340164 Review. Spanish.
-
[Genes in Alzheimer's disease].Rev Neurol. 2006 Mar 1-15;42(5):302-5. Rev Neurol. 2006. PMID: 16538594 Review. Spanish.
Cited by
-
An Integrative Literature Review on the Nomenclature and Definition of Dementia at a Young Age.J Alzheimers Dis. 2021;83(4):1891-1916. doi: 10.3233/JAD-210458. J Alzheimers Dis. 2021. PMID: 34487041 Free PMC article. Review.
-
Association between NMDA receptor subunit 2b gene polymorphism and Alzheimer's disease in Chinese Han population in Shanghai.Neurosci Bull. 2010 Oct;26(5):395-400. doi: 10.1007/s12264-010-0729-2. Neurosci Bull. 2010. PMID: 20882066 Free PMC article.
-
Blood pressure and Alzheimer's disease: A review of meta-analysis.Front Neurol. 2023 Jan 11;13:1065335. doi: 10.3389/fneur.2022.1065335. eCollection 2022. Front Neurol. 2023. PMID: 36712428 Free PMC article.
-
Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice.Acta Pharmacol Sin. 2020 Feb;41(2):145-153. doi: 10.1038/s41401-019-0257-1. Epub 2019 Jun 18. Acta Pharmacol Sin. 2020. PMID: 31213670 Free PMC article.
-
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.Neurology. 2014 Jul 15;83(3):253-60. doi: 10.1212/WNL.0000000000000596. Epub 2014 Jun 13. Neurology. 2014. PMID: 24928124 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical